NCT03435796 2026-03-04Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsCelgenePhase 2/3 Recruiting1,541 enrolled
NCT03927885 2026-02-19Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced CancerM.D. Anderson Cancer CenterPhase 2/3 Active not recruiting100 enrolled
NCT04208347 2026-01-23Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric CancerRuijin HospitalPhase 2/3 Active not recruiting580 enrolled
NCT07005102 2026-01-23A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerAbbViePhase 2/3 Recruiting694 enrolled
NCT07279792 2025-12-29Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral ResectionAin Shams UniversityPhase 2/3 Completed150 enrolled